Related by context. All words. (Click for frequent words.) 78 proteasome inhibitors 77 mertansine 76 protein kinase inhibitor 76 Carfilzomib 76 imatinib Gleevec ® 75 VEGF inhibitors 75 receptor tyrosine kinase inhibitor 75 thalidomide Thalomid 75 pan HDAC inhibitor 75 vascular disrupting agents 75 erlotinib Tarceva ® 75 Dasatinib 75 HSP# inhibitor 75 Onconase 75 Xanafide 75 bortezomib Velcade 75 YONDELIS 75 targeted antifolate 75 angiogenesis inhibitor 75 MAGE A3 ASCI 75 liposomal formulation 75 PDE4 inhibitor 74 chimeric monoclonal antibody 74 dasatinib Sprycel 74 JAK inhibitor 74 investigational humanized monoclonal antibody 74 histone deacetylase HDAC inhibitor 74 TLR9 agonist 74 targeted radiotherapeutic 74 mTOR inhibitor 74 Daclizumab 74 humanized anti 74 Aplidin 74 MEK inhibitors 74 Aflibercept 74 oral proteasome inhibitor 74 BAY #-# 74 orally bioavailable 74 humanized monoclonal antibody 74 Pertuzumab 74 Genentech Rituxan 74 peripherally acting 74 sorafenib Nexavar 74 sodium glucose cotransporter 74 anticancer agent 73 Crizotinib 73 metaglidasen 73 Elvitegravir 73 selective agonist 73 Squalamine 73 Velcade bortezomib 73 HQK 73 PKC# 73 Anidulafungin 73 selective kinase inhibitor 73 Dapagliflozin 73 PNP inhibitor 73 SERMs 73 histone deacetylase HDAC 73 Maribavir 73 PEG SN# 73 CYT# potent vascular disrupting 73 JAK2 inhibitor 73 anticancer compound 73 IAP inhibitors 73 non nucleoside inhibitor 73 oral prodrug 73 histone deacetylase inhibitor 73 Darinaparsin 73 somatostatin analogue 73 alkylating agent 73 Gleevec imatinib mesylate 73 volociximab 73 PI3K/Akt pathway inhibitor 73 vinca alkaloid 73 Ixabepilone 73 Deforolimus 73 Nexavar ® 73 Gleevec resistant 73 Fc fusion protein 73 Voreloxin 73 Bortezomib 73 Temsirolimus 73 potent anticancer 73 multitargeted 73 rituximab Rituxan 73 targeting CD# 73 humanized monoclonal 73 radiation sensitizer 72 ENMD # 72 BCR ABL inhibitors 72 GW# [003] 72 Elotuzumab 72 orally administered inhibitor 72 novel peptide 72 MEK inhibitor 72 IgG1 monoclonal antibody 72 Factor VIIa 72 multi kinase inhibitor 72 Traficet EN 72 Zolinza 72 tigecycline 72 gefitinib Iressa 72 humanized monoclonal antibodies 72 Alfacell proprietary ribonuclease 72 huC# DM4 72 Nexavar sorafenib 72 CCX# 72 JAK inhibitors 72 vascular disrupting agent 72 novel oral anticoagulant 72 XmAb# 72 selective modulator 72 dasatinib Sprycel ® 72 imatinib Gleevec 72 IMiD 72 tyrosine kinase inhibitor 72 small molecule Hedgehog 72 etanercept Enbrel 72 Guanilib 72 Aliskiren 72 anti CD3 antibody 72 Silodosin 72 Methylnaltrexone 72 small molecule tyrosine 72 Tyrima 72 cytostatic 72 Mipomersen 72 HCV protease inhibitors 72 Dalbavancin 72 CD# monoclonal antibody 72 CCR5 antagonist 71 PEGylated 71 pegylated interferons 71 IAP inhibitor 71 Rituxan rituximab 71 histone deacetylase inhibitors 71 Archexin 71 microtubule inhibitor 71 Panzem 71 sunitinib Sutent ® 71 Omacetaxine 71 humanised monoclonal antibody 71 humanized antibody 71 TNF Tumor Necrosis Factor 71 PEGylated Fab fragment 71 PrevOnco 71 bevacizumab Avastin ® 71 peptibody 71 CYC# 71 PD LID 71 PARP inhibitor 71 Amrubicin 71 immunomodulator 71 AKT inhibitor 71 Epratuzumab 71 mTOR inhibitors 71 epothilones 71 Vidaza azacitidine 71 cetuximab Erbitux R 71 pomalidomide 71 reslizumab 71 AEG# 71 novel immunomodulatory 71 highly selective inhibitor 71 Vidofludimus 71 Talabostat 71 Pemetrexed 71 IMiDs ® 71 Olaparib 71 HuLuc# 71 PRT# 71 depsipeptide 71 evaluating tivozanib 71 OMP #M# 71 echinocandins 71 antisense oligonucleotide 71 virus HCV protease inhibitor 71 meropenem 71 XL# XL# 71 Erlotinib 71 oral antiviral 71 BMS # 71 anti CD3 71 Pralatrexate 71 nucleoside analogues 71 BRAF inhibitor 71 demonstrated antitumor activity 71 RhuDex ® 71 investigational monoclonal antibody 71 LY# [003] 71 Radezolid 71 ixabepilone 71 cediranib 71 MGd 71 docetaxel Taxotere ® 71 BiTE 71 alpha interferon 71 elotuzumab 71 HuMax CD4 71 OncoVex 71 Factor Xa inhibitor 71 nilotinib Tasigna 71 peptidic compound 71 Elesclomol 71 R sorafenib tablets 71 ganetespib 71 protein tyrosine phosphatase 1B 71 Fludara ® 71 Virulizin ® 71 Sudhir Agrawal D.Phil 71 CDK inhibitor 71 Tarceva TM 71 Thiarabine 71 Tofacitinib 71 radezolid 71 Campath ® 71 beta 1a 71 Irinotecan 71 DU #b 71 immunomodulating 70 Panzem R 70 selective inhibition 70 Epothilones 70 HepDirect prodrug 70 CCR2 70 Tarvacin 70 ocular formulation 70 Pazopanib 70 IMA# 70 Romidepsin 70 daptomycin 70 Bucindolol 70 nucleoside analogs 70 VitiGam 70 endothelin receptor antagonists 70 KSP inhibitor 70 Interferon alpha 70 Atrasentan 70 TREANDA 70 Clofarabine 70 hyaluronidase enzyme 70 rxRNA 70 inhibit EGFR 70 MT#/MEDI-# 70 Sym# 70 nucleoside analog 70 modulator SERM 70 cilengitide 70 Eraxis 70 AAG geldanamycin analog 70 TELINTRA 70 visilizumab 70 Seliciclib 70 MKC# MT 70 IMiDs R 70 histone deacetylase HDAC inhibitors 70 tyrosine kinase inhibitor TKI 70 canagliflozin 70 Sphingomab 70 AMN# [001] 70 Ambrisentan 70 sorafenib tablets 70 gamma secretase inhibitor 70 immunotherapeutic agent 70 cathepsin K inhibitor 70 UPLYSO 70 beta interferons 70 Blinatumomab 70 NEUGENE 70 Anavex #-# 70 oxidative stress inducer 70 intranasal formulation 70 Anticalins R 70 antiangiogenic agent 70 oral JAK1 70 Granulocyte Colony Stimulating Factor 70 Orally administered 70 OHR/AVR# 70 immune modulating 70 intravesical instillation 70 NS#/#A protease 70 Symadex 70 erlotinib Tarceva 70 A3 adenosine receptor 70 Tezampanel 70 docetaxel Taxotere R 70 Ridaforolimus 70 novel topoisomerase 70 ceftazidime 70 polymerase inhibitor 70 Aviptadil 70 cancer immunotherapies 70 NXL# 70 subcutaneously administered 70 thrombin receptor 70 thrombopoietin 70 CDDO Im 70 Arcalyst 70 selective estrogen receptor modulator 70 antibody fragment 70 Maxy G# 70 Locked Nucleic Acid LNA 70 insulin sensitizers 70 generation purine nucleoside 70 Saxagliptin 70 BLyS specific 70 Enzastaurin 70 HCV protease inhibitor 70 Pathway Inhibitor 70 Preclinical studies suggest 70 receptor modulators 70 Panzem R NCD 70 CEQ# 70 polycythemia vera PV 70 direct thrombin inhibitors 70 regorafenib 70 Liprotamase 70 novel VDA molecule 70 Belimumab 70 Interferon beta 70 HDACi 70 polymerase inhibitors 70 Ganciclovir 70 immune modulatory 70 RECOTHROM R 70 accumulate preferentially 70 recombinant interferon 70 inhaled formulation 70 JAK3 70 selective antagonist 70 echinocandin 70 vidofludimus 70 Hsp# Inhibitor 70 Solazed TM 70 Gefitinib 70 Anticalin R 70 IL# PE#QQR 70 YONDELIS R 70 2 methoxyestradiol 70 immunotoxin 70 HMG CoA reductase inhibitors 70 anti angiogenic agent 70 ATL# [001] 70 orally dosed 70 Muraglitazar 70 enzyme inhibitor 69 midstage clinical 69 hypomethylating agents 69 Herceptin trastuzumab 69 Trastuzumab DM1 69 fosbretabulin 69 DFMO 69 seliciclib CYC# 69 anticancer therapy 69 polyglutamate 69 Alemtuzumab 69 novel histone deacetylase 69 Zybrestat 69 corticosteroid dexamethasone 69 PEGylated anti 69 DOS# 69 therapeutic monoclonal antibody 69 tumor vascular disrupting 69 EGS# 69 Ecallantide 69 trabectedin 69 STEDESA 69 Sapacitabine 69 retapamulin 69 SAR# [002] 69 OncoVEX 69 alkylating 69 PI3K inhibitors 69 Nilotinib 69 OncoVEX GM CSF 69 SARMs 69 Gemzar ® 69 dexpramipexole 69 taxol 69 MTP inhibitor 69 Anticalin ® 69 oxazolidinone 69 highly selective endothelin 69 paclitaxel Taxol 69 idarubicin 69 systemically administered 69 Aganocide ® 69 interferon IFN 69 anticoagulant reversing agent 69 PEGylated interferon 69 tafamidis 69 SAR# [004] 69 vinca alkaloids 69 ALN TTR# 69 XL# anticancer compounds 69 ADP receptor antagonist 69 amrubicin 69 RNAi therapeutic targeting 69 HCD# [002] 69 pharmacokinetic interactions 69 TG# [003] 69 BAL# [002] 69 selective serotonin 2C receptor 69 SRT# [003] 69 Initiates Clinical 69 PSMA ADC 69 torezolid 69 antisense drug 69 delafloxacin 69 Leukine ® 69 posaconazole 69 pegylated liposomal doxorubicin 69 bendamustine 69 Dacogen decitabine 69 LymphoStat B TM 69 Pimavanserin 69 Civacir 69 HIV integrase inhibitor 69 renin inhibitor 69 MKC# MKC# PP 69 signal transduction inhibitor 69 TLR9 agonists 69 non nucleoside HCV 69 Allovectin 7 69 alpha folate receptor 69 nilotinib Tasigna ® 69 mTOR mammalian target 69 potent topoisomerase II 69 Evoltra ® 69 Vandetanib 69 Onalta 69 HCV NS3 protease 69 selectively inhibits 69 antimetabolite 69 Vaprisol 69 delta isoform 69 Perifosine 69 Homspera TM 69 Romiplostim 69 Darusentan 69 Aurora kinase inhibitor 69 hypoxia activated prodrug 69 anticancer therapeutics 69 atacicept 69 Anticalins 69 myelofibrosis polycythemia vera 69 CDP# 69 selective inhibitor 69 ALN TTR 69 flavopiridol 69 SCH # 69 Panzem NCD 69 trastuzumab DM1 T DM1 69 methylnaltrexone bromide 69 drug zotarolimus 69 CD# antibody [001] 69 nanopharmaceutical 69 cholesteryl ester transfer 69 Ceftaroline 69 gemcitabine Gemzar 69 PORxin TM 69 RGB # 69 ANYARA 69 FOLOTYN ® 69 SinuNase ™ 69 Personalized Immunotherapy 69 OvaRex ® MAb 69 siRNA therapeutic 69 Epidermal Growth Factor Receptor 69 potent antiproliferative 69 preclinically 69 GVAX ® 69 GMX# 69 synthetic retinoid 69 Kinase Inhibitor 69 Teriflunomide 69 Bezielle 69 reformulates existing FDA 69 receptor inhibitor 69 compound AEZS 69 prodrugs 69 MNTX 69 Zoraxel TM 69 Raltegravir 69 neuraminidase inhibitor 69 Plicera 69 immune modulator 69 ALN PCS 69 neuroprotectant 69 temsirolimus 69 calcineurin inhibitors 69 Tamibarotene 69 protein kinase inhibitors 69 antiangiogenesis 69 anti amnesic 69 kidney urologic 69 melanocortin receptor agonists 69 PDX pralatrexate 69 relapsed MM 69 M2 subunit 69 tumor xenograft models 69 ANG# 69 preclinical efficacy 69 SCCHN 69 generation antisense inhibitor 69 anti CD# antibodies 69 ALK inhibitor 69 Janus kinase 69 adenosine A2A 69 immune modulators 69 drug conjugate 69 phase IIb clinical 69 epothilone 69 biologic therapeutics 69 Zarnestra 69 selective estrogen receptor 69 Enzyme Replacement Therapy 69 pegylated 69 Monoclonal antibodies 69 nucleoside analogue 69 Fodosine 69 Aurora Kinase 69 TRX1 69 Tumor Necrosis Factor 69 SPRYCEL ® 68 Imatinib mesylate 68 Onalta ™ 68 anti secretory 68 BRAF inhibitors 68 dihydrofolate reductase 68 cetuximab Erbitux ® 68 DXL# 68 Eculizumab 68 Monoclonal antibody 68 renin inhibitors 68 Sutent sunitinib 68 antimitotic 68 Amplimexon 68 Angiotensin Converting Enzyme 68 AMPK activators 68 vinorelbine tartrate 68 topical antifungal 68 ALK inhibitors 68 JAK1 68 synthetic siRNA 68 antibody MAb 68 Azedra 68 Remicade infliximab 68 selective orally bioavailable 68 Mycamine 68 cyclophilin inhibitors 68 tubulin inhibitor 68 Arranon 68 antiproliferative effects 68 pertuzumab 68 tyrosine kinase inhibitors TKIs 68 rNAPc2 68 HCV NS5B polymerase 68 fluoroquinolone antibiotic 68 chemotherapeutic drug 68 Debio 68 small molecule thrombopoietin 68 Abatacept 68 antitumor 68 Tesmilifene 68 acyclovir Lauriad R 68 5 HT3 antagonist 68 Arimoclomol 68 CA4P 68 thiazolides 68 FK# 68 Annamycin 68 R roscovitine 68 Cethromycin 68 Taxol ® 68 immunotherapeutic 68 Bevacizumab 68 antidiabetic 68 benzimidazole 68 docetaxel Taxotere 68 refractory chronic lymphocytic 68 tyrosine kinase inhibitors 68 Everolimus 68 Boceprevir 68 essential thrombocythemia ET 68 HGS# 68 stable nucleic acid 68 mecamylamine 68 Ceflatonin R 68 oncolytic 68 Protein Kinase C 68 chemotherapy induced neutropenia 68 mild vasodilator 68 immunomodulatory 68 Angiocept 68 paclitaxel Taxol ® 68 irreversible inhibitor 68 vemurafenib 68 antitumoral 68 Ceflatonin 68 Hsp# inhibitors 68 familial amyloidotic polyneuropathy FAP 68 Aplidin R 68 metastatic neuroendocrine tumors 68 ospemifene 68 octreotide acetate 68 mesylate 68 T#I [002] 68 ketolide antibiotic 68 anticancer therapies 68 mitogen activated ERK kinase 68 cidofovir 68 beta lactam 68 Phase #b/#a clinical 68 CCR5 inhibitor 68 Anticalins ® 68 ZOLINZA 68 Valproic acid 68 Kuvan sapropterin dihydrochloride 68 trastuzumab Herceptin R 68 ONX 68 samalizumab 68 Safinamide 68 hormone LHRH antagonist 68 sitaxsentan 68 PARP inhibitors 68 Lacosamide 68 basiliximab 68 CTLA4 Ig 68 Lubiprostone 68 superficial bladder cancer 68 cyclin dependent kinase inhibitor 68 Maraviroc 68 Omacetaxine mepesuccinate 68 Olmesartan 68 alefacept 68 Chemokine Receptor 68 TBC# 68 DPP4 68 novel orally administered 68 Soliris eculizumab 68 small molecule activators 68 tranilast 68 HuMax CD# 68 tolevamer 68 HuMax EGFr 68 Navelbine ® 68 panitumumab Vectibix 68 antifolates 68 pancreatic enzyme replacement 68 defensin mimetic antibiotic 68 diarrhea predominant irritable 68 INTEGRILIN ® 68 Ozarelix 68 CD3 monoclonal antibody 68 engineered RAP peptides 68 vivo validation 68 IMiDs ® compound 68 xanthine oxidase inhibitor 68 anionic backbone 68 potently inhibit 68 Elagolix 68 Immunotherapeutic 68 EGFR inhibitors 68 CB1 antagonists 68 mGluR5 NAM 68 bexarotene 68 lumiliximab 68 pathophysiological effects 68 Targretin 68 Bosutinib 68 Tesetaxel 68 ALN HPN 68 TKB# 68 combretastatin A4 phosphate CA4P 68 brostallicin 68 Sphingomab TM 68 HCV protease 68 Cytotoxic 68 cutaneous T 68 immunomodulatory therapy 68 Xeloda ® 68 CRTH2 68 oncolytic virus therapies 68 antisense inhibitors 68 metastatic colorectal 68 isoform selective 68 Marqibo TM 68 relapsed leukemia 68 Trabectedin 68 imatinib mesylate 68 cleavable linker 68 Pradefovir 68 factor Xa 68 efalizumab 68 Golimumab 68 peptidomimetic 68 PI3K inhibitor 68 demethylating agents 68 Laquinimod 68 reverse transcriptase inhibitors 68 epigenetic therapies 68 PSN# [001] 68 OXi# 68 Bafetinib 68 lipid nanoparticle 68 5alpha reductase 68 Cloretazine R 68 Doxil ® 68 bevacizumab Avastin 68 adult mesenchymal stem 68 therapeutic monoclonal antibodies 68 tubulin binding 68 long acting muscarinic 68 alvespimycin 68 CTAP# Capsules 68 Azacitidine 68 Nitazoxanide 68 EGFR tyrosine kinase inhibitors 68 Peginterferon alfa 2b 68 sphingosine 1 68 Zorbtive TM 68 EGFR HER2 68 novel anticancer 68 liposome encapsulated 68 fludarabine phosphate 68 pemetrexed Alimta 68 OMNARIS HFA 68 indibulin 68 #I TM# 68 selective androgen receptor modulator 68 Ixempra 68 DNA intercalator 68 midstage trials 68 Glufosfamide 68 Trastuzumab 68 Clevudine 68 Cathepsin S 68 AP# [003] 68 XYOTAX TM 68 LHRH antagonist 68 investigational pharmacologically unique 68 HCV polymerase inhibitors 68 oral Janus kinase 68 HSP# inhibitors 68 Reverset 68 Yondelis ® 68 nucleotide analogue 68 Vidaza R 68 PI3K/mTOR 68 PF # [002] 68 multikinase inhibitor 68 lapatinib Tykerb 68 macrolide antibiotics 68 CBLC# 68 Vectibix panitumumab 68 G#DT 68 M# rationally 68 humanized antibodies 68 riociguat 68 selective adenosine 68 ZACTIMA 68 Cloretazine 68 chemopreventive agent 68 TLR8 agonist 68 HDAC Inhibitor 68 Hycamtin 68 Rigel R# 67 tasocitinib 67 Tumour Vascular Disrupting Agent 67 Lenalidomide 67 molecular imaging radiopharmaceutical 67 Paraplatin ® 67 EndoTAG TM -1 67 DEB# 67 beta lactams 67 selective immunoproteasome inhibitor 67 ISF# 67 novel prodrug 67 nucleotide analogs 67 Clolar ® 67 antitumour 67 taxane derivative 67 Neulasta ® 67 synthetic peptide 67 PROCHYMAL 67 Litx 67 GSK# [002] 67 INCB# [003] 67 immunomodulatory properties 67 antiplatelet agent 67 ganciclovir 67 antisense inhibitor 67 CD# antibodies 67 Fluconazole 67 Lenocta 67 Anti VEGF 67 Akt inhibitor 67 Telintra 67 HCV polymerase 67 biologic therapy 67 RAV# 67 K ras mutations 67 Milnacipran 67 Meets Primary Endpoint 67 GRNVAC1 67 ocrelizumab 67 phase III isavuconazole 67 VEGF inhibitor 67 Cannabinor 67 P#X# antagonist 67 neratinib 67 uricase 67 tiapamil 67 Gemcitabine 67 endothelin receptor 67 PLX# 67 myeloproliferative diseases 67 immunotherapeutic vaccine 67 oral dihydropyrimidine dehydrogenase DPD 67 cetuximab Erbitux 67 candidates Azedra TM 67 CD# CEA 67 fluoropyrimidine 67 vapreotide acetate 67 patented Bioral 67 EndoTAG TM 67 sulindac 67 anti CD3 monoclonal 67 monoclonal antibody mAb 67 Omnitarg 67 Delafloxacin 67 tenofovir Viread 67 either acutely decompensated 67 teriflunomide 67 lipoglycopeptide 67 epithelial tumors 67 Taxotere docetaxel 67 azoles 67 CG# [003] 67 gastrointestinal stromal tumors GISTs 67 liposomal doxorubicin 67 trastuzumab Herceptin 67 rhIL 7 67 monoclonal antibody MAb 67 SNRI 67 TriRima 67 antifungal agent 67 outlicensed 67 GRNOPC1 contains 67 demethylating agent 67 investigational pan BCR 67 cannabinor 67 exon skipping 67 uric acid lowering 67 Interferon alfa 67 Vorinostat 67 sunitinib Sutent 67 Cetuximab Erbitux 67 Argatroban 67 Piperacillin 67 Anti angiogenic 67 DiLA2 67 LymphoStat B belimumab 67 anti angiogenic agents 67 nanoviricides 67 AMD# [003] 67 microtubule targeting 67 cyclophilin inhibitor 67 sunitinib malate 67 antiangiogenic 67 mapatumumab 67 GSK '# 67 Denufosol 67 Ciclesonide 67 Hedgehog Pathway Inhibitor 67 Bazedoxifene 67 Exelixis compounds 67 Friedreich Ataxia FRDA 67 nitric oxide donating prostaglandin 67 denileukin diftitox 67 estrogen receptor antagonist 67 VEGF receptor 67 Multimeric 67 fusion inhibitor 67 aripiprazole Abilify 67 Pegloticase 67 drug ISA# 67 Cyclosporin 67 Cetrorelix 67 sulfonylhydrazine class 67 insulin sensitizer 67 Doxil 67 Vaxfectin 67 adecatumumab MT# 67 IgG1 antibody 67 Aptivus ® 67 acadesine 67 MT# MEDI 67 antineoplastic 67 NEUGENE antisense 67 Zalypsis 67 Rilonacept 67 Vicinium TM 67 Vfend 67 Genentech Herceptin 67 anti angiogenic drugs 67 Bendamustine 67 IMiDs 67 Enkephalin 67 Cleviprex TM clevidipine 67 molecularly targeted 67 liposomal amphotericin B 67 RhuDex R 67 antiarrhythmic 67 delipidation 67 Aurora kinase 67 chemotherapeutic agent 67 Gleevec imatinib 67 tipifarnib 67 LHRH antagonists 67 trastuzumab DM1 67 bevacizumab Avastin R 67 TAFA# 67 lenalidomide Revlimid R 67 dihydrochloride 67 Abiraterone acetate 67 2DG 67 sargramostim 67 small molecule glucokinase 67 specific lectin receptors 67 Albuferon TM 67 eltrombopag 67 GRN# 67 intravenously administered 67 IMPDH inhibitor 67 fostamatinib 67 Certolizumab pegol 67 reversible inhibitor 67 OXIGON TM 67 Bruton tyrosine kinase Btk 67 polysaccharide polymer 67 Fulvestrant 67 beta lactamase inhibitor 67 investigational compounds 67 Proxinium TM 67 prokinetic agent 67 LT NS# 67 recurrent glioblastoma multiforme 67 Neulasta R 67 5 HT6 receptor 67 inverse agonist 67 Adentri 67 itraconazole Sporanox 67 cMET 67 prostanoid 67 GV# [001] 67 Levoleucovorin 67 endogenous ligands 67 marketed pegylated interferons 67 bleomycin 67 immune stimulatory 67 Firazyr 67 Onalta TM 67 immunoconjugate 67 efaproxiral 67 chemokine receptor 67 RhuDex TM 67 non nucleoside 67 ara C 67 Onco TCS 67 deacetylase inhibitors 67 Specifid 67 Intravenous CP 67 FGFR 67 OvaRex R 67 candidate deforolimus 67 Teplizumab 67 Leukine 67 ATL# [002] 67 Vicriviroc 67 entinostat 67 Kevetrin ™ 67 MOVIPREP R 67 NV1FGF 67 RNAi Therapeutic 67 mGluR2 positive 67 molecular chaperone regulator 67 ® bortezomib 67 mGluR2 NAM 67 orally inhaled 67 Avanafil 67 ZD# [001] 67 TLR agonists 67 Apoptone 67 TPI ASM8 67 histamine dihydrochloride 67 EZN